Filter
1

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

for
Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
Location: Farmington Hills MI, Indianapolis IN, Dallas TX,
Sponsor: Hummingbird Bioscience

Sex: All

Age: 18+

Code: NCT06956690

Phase1, Phase2, Recruiting

A Study of MGC028 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, NSCLC Adenocarcinoma, Cholangiocarcinoma,
Location: Boston MA, New York NY, Grand Rapids MI, San Antonio TX,
Sponsor: MacroGenics

Sex: All

Age: 18+

Code: NCT06723236

Phase1, Recruiting

A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies

for
NSCLC
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Ellipses Pharma

Sex: All

Age: 18+

Code: NCT05443126

Phase1, Phase2, Recruiting

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

for
Lung Adenocarcinoma,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 22+

Code: NCT07235280

Early_phase1, Recruiting

The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer

for
Lung Cancer - Non Small Cell
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18+

Code: NCT07216209

Recruiting

Interested in new non small cell lung cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

for
Lung Non-Small Cell Carcinoma
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07323641

Phase2, Recruiting

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)

for
Small Cell Lung Cancer Extensive Stage, Brain Metastases,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT07139990

Phase1, Recruiting

Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy

for
Lung Neoplasms, Carcinoma, Non-Small-Cell Lung,
Location: Baltimore MD, Iowa City IA
Sponsor: Andarix Pharmaceuticals

Sex: All

Age: 21+

Code: NCT00100256

Phase1, Phase2, Recruiting